By: IPP Bureau
Last updated : July 30, 2026 10:03 am
FMCG business records 9.5% growth as premium brands, rural demand and innovation drive performance
Dabur India Ltd. reported a strong financial performance for the first quarter of FY27, with consolidated net profit rising 15 per cent year-on-year to Rs. 591 crore, supported by robust growth across its FMCG, healthcare and foods businesses despite inflationary pressures and geopolitical uncertainties.
The company posted consolidated revenue of Rs. 3,761 crore, up 10.6 per cent from the corresponding quarter last year. Its India FMCG business grew 9.5 per cent, driven by an underlying volume growth of 5 per cent, while operating profit increased 11 per cent during the quarter.
Mohit Malhotra, Global Chief Executive Officer, Dabur India Ltd., said, "This marks the third straight quarter of double-digit profit growth for Dabur. The quarter unfolded against a backdrop of persistent inflationary pressures, heightened geopolitical uncertainties in the MENA region, and volatile commodity markets.
“In this hyper-inflationary environment, our disciplined cost management with Project Samriddhi, operational efficiencies and judicious price increases helped report healthy profit growth during the quarter. Dabur ended the first quarter of 2026-27 with an 11% growth in Operating Profit. Net Profit surged 15% to Rs. 591 crore,” added Malhotra.
The company said its premiumisation strategy continued to deliver results, with premium brands growing at twice the pace of its regular portfolio. New product launches, including Siens and Cheers, contributed 2.6 per cent of revenue during the quarter.
Dabur reported broad-based growth across its business verticals. The Home & Personal Care (HPC) business grew 12.3 per cent, Food & Beverages increased 7.2 per cent, while the Healthcare business registered 5.5 per cent growth.
Within the HPC portfolio, the shampoo business was the strongest performer with 23 per cent growth, followed by hair oils at 17.6 per cent and oral care at 9 per cent.
The toothpowder segment grew 13.1 per cent, while the Skin & Salon portfolio, led by Gulabari, Fem and Oxylife, recorded 8.1 per cent growth. The Home Care business rose 6 per cent despite supply chain disruptions linked to the Middle East conflict.
In the healthcare segment, the digestives portfolio grew 11.2 per cent, with Hajmola Tablets, Isabgol and PudinHara registering double-digit growth. Honitus expanded 28 per cent, health juices increased 24 per cent, while Dabur Honey posted 8 per cent growth.